ResMed Inc. (RMD)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
Mick Farrell
Employees:
7,240
9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA 92123
8587462400

ResMed, Inc. engages in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders including sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its product portfolio includes obstructive sleep apnea, and other respiratory disorders that occur during sleep. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.

Data derived from most recent annual or quarterly report
Market Cap 34.758 Billion Shares Outstanding145.723 Million Avg 30-day Volume 435.93 Thousand
P/E Ratio75.9717 Dividend Yield0.6338 EPS1.4
Price to Revenue11.2765 Debt to Equity0.2271 EBITDA1.11 Billion
Price to Book Value12.4924 Operating Margin28.267999999999997 Enterprise Value36.409 Billion
Current Ratio1.727 EPS Growth-0.241 Quick Ratio0.998
1 Yr BETA 0.8525 52-week High/Low 300.86 / 178.46 Profit Margin14.843
Operating Cash Flow Growth-8.1691 Altman Z-Score14.1368 Free Cash Flow to Firm 449.492 Million
View SEC Filings from RMD instead.

View recent insider trading info

Funds Holding RMD (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding RMD BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

37.8 Thousand total shares from 9 transactions

Exercise Derivative Conversion (M)

32.4 Thousand total shares from 6 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

DOUGLAS ROBERT ANDREW PRESIDENT AND COO

  • Officer
330,268 2022-01-18 16

FARRELL MICHAEL J. CHIEF EXECUTIVE OFFICER

  • Officer
542,514 2022-01-18 6

SANDERCOCK BRETT CHIEF FINANCIAL OFFICER

  • Officer
123,854 2022-01-10 15

PENDARVIS DAVID CHIEF ADMINISTRATION OFFICER

  • Officer
116,035 2022-01-03 16

HOLLINGSHEAD JAMES PRESIDENT, SLEEP BUSINESS

  • Officer
76,721 2021-12-01 15

LEONG JUSTIN PRESIDENT, ASIA LATIN AMERICA

  • Officer
48,391 2021-11-24 6

BURT CAROL

  • Director
13,095 2021-11-22 5

RESMED INC

  • Director
13,823 2021-11-18 1

TAYLOR RONALD R

  • Director
19,725 2021-11-18 2

FARRELL PETER C

  • Director
193,797 2021-11-18 3

DREXLER KAREN

  • Director
9,154 2021-11-18 1

GILL HARJIT

  • Director
6,185 2021-11-18 1

DE WITTE JAN

  • Director
4,989 2021-11-18 2

TAN DESNEY

  • Director
956 2021-11-18 1

HERNANDEZ JOHN

  • Director
956 2021-11-18 1

GHOSHAL KAUSHIK PRESIDENT, SAAS BUSINESS

  • Officer
11,171 2021-11-16 4

SODHI RAJWANT PRESIDENT, SAAS BUSINESS

  • Officer
0 2021-10-07 10

SULPIZIO RICHARD

  • Director
12,867 2020-11-19 0

MCHALE RICHARD PRESIDENT, RC BUSINESS

  • Officer
No longer subject to file 2020-08-13 0

WAREHAM JOHN P

  • Director
11,300 2019-11-01 0

PACE GARY W

  • RETIRED DIRECTOR
No longer subject to file 2019-07-24 0

ROBERTS CHRISTOPHER G

  • RETIRED DIRECTOR
No longer subject to file 2017-11-16 0

REISER ANNE FORMER PRESIDENT-RESMED EUROPE

  • Officer
No longer subject to file 2017-08-18 0

DARKIN DONALD PRES. GLOBAL INNOVATION AND OP

  • Officer
No longer subject to file 2016-08-15 1

QUINN MICHAEL A

  • Director
1,563,000 2013-08-28 1

JACOBSEN STEIN PRESIDENT - EUROPE

  • Officer
52,143 2011-11-23 0

GALLAHUE KIERAN CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
56,922 2011-01-05 0

MCCARTHY DONAGH

  • Director
No longer subject to file 2008-11-20 1

BEIJER LASSE COO-EUROPE

  • Officer
25 2008-08-26 0

EISEN PAUL SR. V P, ASIA PACIFIC

  • Officer
0 2008-05-22 1

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

FARRELL MICHAEL J. - Officer CHIEF EXECUTIVE OFFICER

2022-01-20 16:37:44 -0500 2022-01-18 S 5,675 $241.94 d 405,229 direct 1.4288 1.4288 2 0.0 1

DOUGLAS ROBERT ANDREW - Officer PRESIDENT AND COO

2022-01-20 17:40:21 -0500 2022-01-18 S 8,000 $247.80 d 17,175 direct 1.4288 1.4288 2 0.0 1

FARRELL MICHAEL J. - Officer CHIEF EXECUTIVE OFFICER

2022-01-20 16:37:44 -0500 2022-01-18 M 5,675 $57.76 a 410,904 direct 1.4288 1.4288 2 0.0 1

DOUGLAS ROBERT ANDREW - Officer PRESIDENT AND COO

2022-01-20 17:40:21 -0500 2022-01-18 M 8,000 $58.24 a 25,175 direct 1.4288 1.4288 2 0.0 1

FARRELL MICHAEL J. - Officer CHIEF EXECUTIVE OFFICER

2022-01-20 16:37:44 -0500 2022-01-18 M 5,675 d 128,315 direct yes

DOUGLAS ROBERT ANDREW - Officer PRESIDENT AND COO

2022-01-20 17:40:21 -0500 2022-01-18 M 8,000 d 78,098 direct yes

SANDERCOCK BRETT - Officer CHIEF FINANCIAL OFFICER

2022-01-11 17:18:04 -0500 2022-01-10 S 2,500 $235.00 d 106,354 direct 3.0839 -2.5433 3.2723 3 -2.5433 6

SANDERCOCK BRETT - Officer CHIEF FINANCIAL OFFICER

2022-01-11 17:18:04 -0500 2022-01-10 M 2,500 $57.76 a 108,854 direct 3.0839 -2.5433 3.2723 3 -2.5433 6

SANDERCOCK BRETT - Officer CHIEF FINANCIAL OFFICER

2022-01-11 17:18:04 -0500 2022-01-10 M 2,500 d 17,500 direct

PENDARVIS DAVID - Officer CHIEF ADMINISTRATION OFFICER

2022-01-04 18:12:52 -0500 2022-01-03 S 1,544 $258.52 d 116,035 direct -1.2013 -0.2329 0.0 1 -3.0686 3

LEONG JUSTIN - Officer PRESIDENT, ASIA LATIN AMERICA

2022-01-04 17:42:14 -0500 2021-12-31 F 562 $259.47 d 49,295 direct -1.2013 -0.2329 0.0 1 -3.0686 3

DOUGLAS ROBERT ANDREW - Officer PRESIDENT AND COO

2021-12-17 11:24:13 -0500 2021-12-15 M 8,000 d 86,098 direct

FARRELL MICHAEL J. - Officer CHIEF EXECUTIVE OFFICER

2021-12-17 11:23:04 -0500 2021-12-15 M 5,675 d 133,990 direct yes

DOUGLAS ROBERT ANDREW - Officer PRESIDENT AND COO

2021-12-17 11:24:13 -0500 2021-12-15 S 8,000 $256.52 d 17,175 direct -1.9567 3.5932 3.5932 6 -1.9567 2

FARRELL MICHAEL J. - Officer CHIEF EXECUTIVE OFFICER

2021-12-17 11:23:04 -0500 2021-12-15 S 5,675 $255.53 d 405,229 direct -1.9567 3.5932 3.5932 6 -1.9567 2

DOUGLAS ROBERT ANDREW - Officer PRESIDENT AND COO

2021-12-17 11:24:13 -0500 2021-12-15 M 8,000 $58.24 a 25,175 direct -1.9567 3.5932 3.5932 6 -1.9567 2

FARRELL MICHAEL J. - Officer CHIEF EXECUTIVE OFFICER

2021-12-17 11:23:04 -0500 2021-12-15 M 5,675 $57.76 a 410,904 direct -1.9567 3.5932 3.5932 6 -1.9567 2

SANDERCOCK BRETT - Officer CHIEF FINANCIAL OFFICER

2021-12-14 15:48:27 -0500 2021-12-10 M 2,500 d 20,000 direct yes

SANDERCOCK BRETT - Officer CHIEF FINANCIAL OFFICER

2021-12-14 15:48:27 -0500 2021-12-10 S 2,500 $264.92 d 106,354 direct -1.0875 2.0034 2.0034 6 -3.3248 4

SANDERCOCK BRETT - Officer CHIEF FINANCIAL OFFICER

2021-12-14 15:48:27 -0500 2021-12-10 M 2,500 $57.76 a 108,854 direct -1.0875 2.0034 2.0034 6 -3.3248 4

PENDARVIS DAVID - Officer CHIEF ADMINISTRATIVE OFFICER

2021-12-06 16:57:26 -0500 2021-12-03 S 1,544 $257.93 d 117,579 direct yes 0.7935 -3.5538 -10.5111 0.7935 2 -10.7856 23

HOLLINGSHEAD JAMES - Officer PRESIDENT, SLEEP BUSINESS

2021-12-01 19:16:06 -0500 2021-12-01 S 2,400 $256.84 d 76,721 direct yes -0.4299 3.3922 -1.4538 4.7444 5 -7.2886 26

FARRELL MICHAEL J. - Officer CHIEF EXECUTIVE OFFICER lisette & michael farrell family foundation

2021-12-01 19:32:50 -0500 2021-11-30 G 3,880 a 3,880 indirect -0.4299 3.3922 -1.4538 4.7444 5 -7.2886 26

FARRELL MICHAEL J. - Officer CHIEF EXECUTIVE OFFICER lisette and michael farrell family trust

2021-12-01 19:32:50 -0500 2021-11-30 G 3,880 d 5,090 indirect -0.4299 3.3922 -1.4538 4.7444 5 -7.2886 26

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
RESMED INC RMD 2022-01-25 18:45:03 UTC -0.2443 0.3143 3300000
RESMED INC RMD 2022-01-25 18:15:03 UTC -0.2443 0.3143 3400000
RESMED INC RMD 2022-01-25 17:45:03 UTC -0.2443 0.3143 3400000
RESMED INC RMD 2022-01-25 17:15:03 UTC -0.2443 0.3143 3400000
RESMED INC RMD 2022-01-25 16:45:04 UTC -0.2443 0.3143 3400000
RESMED INC RMD 2022-01-25 16:15:03 UTC -0.2443 0.3143 3400000
RESMED INC RMD 2022-01-25 15:45:03 UTC -0.2443 0.3143 3400000
RESMED INC RMD 2022-01-25 15:15:03 UTC -0.2443 0.3143 3400000
RESMED INC RMD 2022-01-25 14:45:04 UTC -0.2443 0.3143 3300000
RESMED INC RMD 2022-01-25 14:15:03 UTC -0.2443 0.3143 3300000
RESMED INC RMD 2022-01-25 13:45:03 UTC -0.3059 0.3759 3300000
RESMED INC RMD 2022-01-25 13:15:03 UTC -0.3059 0.3759 3300000
RESMED INC RMD 2022-01-25 12:45:03 UTC -0.3059 0.3759 3200000
RESMED INC RMD 2022-01-24 22:15:03 UTC -0.3151 0.3851 3300000
RESMED INC RMD 2022-01-24 21:45:03 UTC -0.3151 0.3851 3300000
RESMED INC RMD 2022-01-24 21:15:03 UTC -0.3151 0.3851 3300000
RESMED INC RMD 2022-01-24 20:45:03 UTC -0.3256 0.3956 3300000
RESMED INC RMD 2022-01-24 20:15:04 UTC -0.3256 0.3956 3300000
RESMED INC RMD 2022-01-24 19:45:04 UTC -0.3256 0.3956 3300000
RESMED INC RMD 2022-01-24 19:15:03 UTC -0.3256 0.3956 3300000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Absolute 500 Core Fund RMD -22.0 shares, $-3240.38 2020-03-31 N-PORT
FundVantage Trust- Gotham Defensive Long Fund RMD -25.0 shares, $-3682.25 2020-03-31 N-PORT
FundVantage Trust- Gotham Neutral 500 Fund RMD -59.0 shares, $-11447.18 2021-03-31 N-PORT
Nuveen Investment Trust- Nuveen Equity Market Neutral Fund RMD -550.0 shares, $-113217.5 2021-05-31 N-PORT
Nuveen Investment Trust II- Nuveen Equity Long/Short Fund RMD -1250.0 shares, $-363162.5 2021-08-31 N-PORT
FundVantage Trust- Gotham Enhanced 500 Plus Fund RMD -32.0 shares, $-8433.6 2021-09-30 N-PORT
FundVantage Trust- Gotham Hedged Core Fund RMD -2.0 shares, $-527.1 2021-09-30 N-PORT
VANGUARD MONTGOMERY FUNDS- VANGUARD MARKET NEUTRAL FUND RMD -3559.0 shares, $-937974.45 2021-09-30 N-PORT
GLENMEDE FUND INC- Quantitative U.S. Long/Short Equity Portfolio RMD -2500.0 shares, $-657275.0 2021-10-31 N-PORT
GLENMEDE FUND INC- Quantitative U.S. Total Market Equity Portfolio RMD -440.0 shares, $-115680.4 2021-10-31 N-PORT

Elevate your investments